NuVasive revenues up 3.7% in Q2 & 4 other insights

Spinal Tech

In the second quarter of 2019, NuVasive reported a 3.7 percent year-over-year increase in revenues.

Four things to know:

1. Second-quarter revenues increased to $292.1 million from $281.6 million for the same period last year.

2. The company reported $214.5 million in unadjusted gross profits for the quarter. NuVasive also reported an adjusted profit margin of 10.3 percent and diluted earnings of $0.29 per share for the quarter.

3. NuVasive maintained its full-year revenue estimates of $1.14 billion to $1.16 billion.

"NuVasive continued to deliver consistent revenue growth in the second quarter 2019, with a notably solid performance from the U.S. Hardware business," said NuVasive CEO J. Christopher Barry.

4. Mr. Barry said the company saw "meaningful case volume growth," because of continued adaptation of the company's X360 system.

"Our strong profitability results over the first half of the year demonstrate the clear initiatives and focused execution throughout the business and are reflected in our raised full year 2019 [non-adjusted] guidance for operating margin and earnings per share," Mr. Barry said.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers